Hongjun Li Selected Research

Neurturin

1/2013	Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
8/2012	The delivery of tyrosine hydroxylase accelerates the neurorestoration of Macaca Rhesus model of Parkinson's disease provided by Neurturin.
1/2009	Study on construction, expression, and biological activity of recombinant adenovirus of neurturin.
4/2003	Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongjun Li Research Topics

Disease

46	Neoplasms (Cancer) 03/2022 - 02/2002
12	Infections 04/2021 - 01/2012
11	COVID-19 04/2021 - 01/2020
8	Inflammation (Inflammations) 01/2022 - 10/2018
8	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2013
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2018
6	Erectile Dysfunction 07/2022 - 01/2017
6	Carcinogenesis 10/2021 - 01/2018
5	Parkinson Disease (Parkinson's Disease) 04/2013 - 04/2003
4	Lower Urinary Tract Symptoms 09/2022 - 01/2019
4	Rotavirus Infections 01/2022 - 02/2011
4	Necrosis 11/2021 - 04/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2016
4	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2015
4	HIV Infections (HIV Infection) 01/2019 - 11/2014
3	Pain (Aches) 09/2022 - 10/2014
3	Diarrhea 01/2022 - 01/2020
3	Fibrosis (Cirrhosis) 10/2021 - 08/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 07/2016
3	Male Infertility (Male Sterility) 01/2021 - 01/2015
3	Melanoma (Melanoma, Malignant) 01/2021 - 02/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 08/2018
3	Cognitive Dysfunction 01/2021 - 01/2020
3	Prostatitis 10/2020 - 07/2004
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2020 - 01/2019
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 08/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2017
3	Poisoning 09/2015 - 08/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2013 - 04/2003
2	Edema (Dropsy) 11/2022 - 05/2015
2	Hypogonadism (Hypergonadotropic Hypogonadism) 09/2022 - 08/2004
2	Leukemia 03/2022 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2022
2	Neurocognitive Disorders (Clerambault Syndrome) 01/2022 - 06/2012
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
2	Pneumonia (Pneumonitis) 04/2021 - 04/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2021 - 01/2021
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 11/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2020
2	Azoospermia 01/2021 - 03/2020
2	Hyperglycemia 01/2021 - 11/2020
2	Pathologic Processes 01/2021 - 01/2018
2	Infertility (Sterility) 01/2021 - 07/2004
2	Pelvic Pain 10/2020 - 12/2004
2	Lymphopenia (Lymphocytopenia) 08/2020 - 06/2020
2	Neuroblastoma 01/2020 - 10/2019
2	Hyperplasia 01/2020 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 11/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 12/2019 - 02/2009
9	VaccinesIBA 01/2022 - 02/2011
8	Pharmaceutical PreparationsIBA 01/2021 - 10/2014
7	MicroRNAs (MicroRNA)IBA 08/2022 - 11/2014
7	Small Interfering RNA (siRNA)IBA 10/2020 - 02/2009
6	RNA (Ribonucleic Acid)IBA 08/2022 - 01/2020
6	Long Noncoding RNAIBA 10/2021 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	Nucleic AcidsIBA 04/2021 - 11/2019
5	Testosterone (Sustanon)FDA Link 01/2021 - 08/2018
4	CateninsIBA 01/2022 - 01/2015
4	AndrogensIBA 12/2021 - 08/2004
4	AntigensIBA 04/2021 - 12/2004
4	CytokinesIBA 01/2021 - 09/2015
4	Insulin (Novolin)FDA Link 01/2021 - 04/2018
4	Biological ProductsIBA 08/2020 - 01/2018
4	C-Reactive ProteinIBA 08/2020 - 09/2018
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2018
4	NeurturinIBA 01/2013 - 04/2003
3	Circular RNAIBA 08/2022 - 11/2019
3	AntibodiesIBA 01/2022 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 06/2019
3	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2018
3	HydrogelsIBA 01/2021 - 11/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2018
3	Genetic Markers (Genetic Marker)IBA 01/2021 - 01/2020
3	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 09/2018 - 05/2015
2	dicyclohexyl 2,3-epoxysuccinate (Ep-1)IBA 11/2022 - 10/2019
2	Hematoxylin (Haematoxylon)IBA 08/2022 - 12/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 08/2022 - 12/2014
2	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 01/2017
2	Rotavirus VaccinesIBA 01/2022 - 02/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 12/2020
2	Phosphotransferases (Kinase)IBA 10/2021 - 06/2019
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2021 - 01/2019
2	Therapeutic UsesIBA 07/2021 - 02/2021
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 04/2021 - 01/2021
2	PolymersIBA 01/2021 - 06/2015
2	6-methyladenineIBA 01/2021 - 01/2021
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2020 - 01/2020
2	Peroxidase (Myeloperoxidase)IBA 06/2019 - 05/2015

Therapy/Procedure

28	Therapeutics 09/2022 - 02/2002
11	Drug Therapy (Chemotherapy) 11/2021 - 02/2002
6	Transplantation 10/2021 - 04/2013
5	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 02/2016
3	Immunotherapy 03/2021 - 09/2020
3	Radiotherapy 01/2020 - 02/2002
2	Castration 01/2022 - 10/2018
2	Intravenous Injections 10/2020 - 10/2018